Imidazopyridines as serotonergic 5-HT.sub.3 -antagonists
First Claim
1. A compound of the formula ##STR40## the stereoisomers and pharmaceutically acceptable salts thereof wherein Rl is selected from the group consisting of H and C1-6 alkyl;
- R2 is selected from the group consisting of H and halogen;
Y is selected from the group consisting of NH and O;
d is 0 or 1; and
R'"'"'5 is C1-7 alkyl C3-8 cycloalkyl C3-8 cycloalkyl-C1-2 -alkyl, C2-7 alkenyl, C2-7 alkenyl-C1-4 -alkyl or phenyl-C1-6 alkyl.
0 Assignments
0 Petitions
Accused Products
Abstract
The imidazopyridines compounds of the present invention are serotonergic 5-HT3 antagonists. As such they are useful for the treatment of humans and animals wherein antagonism of 5-HT3 receptors is beneficial. Therapy is indicated for, but not limited to, the treatment of anxiety, psychoses, depression (especially depression accompanied by anxiety), cognitive disorders, substance abuse dependence and withdrawal, gastrointestinal motility disturbances (including esophageal reflux, dyspepsia, gastric stasis, irritable bowel syndrome), emesis caused by chemotherapeutic agents, and visceral pain. Additionally, the compounds of the present invention may find utility as enhancers of nasal absorption of bioactive compounds.
39 Citations
11 Claims
-
1. A compound of the formula ##STR40## the stereoisomers and pharmaceutically acceptable salts thereof wherein Rl is selected from the group consisting of H and C1-6 alkyl;
- R2 is selected from the group consisting of H and halogen;
Y is selected from the group consisting of NH and O; d is 0 or 1; and R'"'"'5 is C1-7 alkyl C3-8 cycloalkyl C3-8 cycloalkyl-C1-2 -alkyl, C2-7 alkenyl, C2-7 alkenyl-C1-4 -alkyl or phenyl-C1-6 alkyl. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11)
- R2 is selected from the group consisting of H and halogen;
Specification